Please assess the completion status of the following clinical trial:

Trial Title: Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* male patients diagnosed with T1C or T2 prostate cancer, awaiting prostatectomy~Exclusion Criteria:~* unable to give informed consent~* contraindication to MRI or MRI contrast agent~* claustrophobia~* renal impairment~* prior hormonal or radiation therapy for prostate cancer~* active prostatitis~* moderate to severe rectal inflammation~* previous rectal surgery~* prostate biopsy within 4 weeks of planned MRI

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single arm study (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).